PRIMROSE PHARMA
Last board
No change since 2016- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “De gemachtigden verbinden de vennootschap, binnen de perken van de hun verleende volmacht…”deed of 07-06-2016
Mandates through the years
1 nameManager (not named in the articles)
Earlierend not dated
Mandates as a list
-
- Manager (not named in the articles), appointed by deed of 07-06-2016, last mentioned in 2016
Control
PRIMROSE PHARMA was absorbed by on 22-11-2018.
Capital
- Capital
- €100,000
- Shares
- 1,000
- Contribution per share
- €100
- Equity per share
- -€339 in 2018
- Source
- deed of 16-10-2018
Articles of association
deed of 07-06-2016 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Friday of November at 20:00
Founders
At incorporation
deed of 07-06-2016 ↗
- founder
- founder
Capital transactions
Capital over time
- 16-10-2018 Capital stated in the deed · €100,000 · 1,000 shares
- 07-06-2016 Incorporation · €100,000 · 1,000 shares